DE936592C - Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants - Google Patents

Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants

Info

Publication number
DE936592C
DE936592C DEP12946A DEP0012946A DE936592C DE 936592 C DE936592 C DE 936592C DE P12946 A DEP12946 A DE P12946A DE P0012946 A DEP0012946 A DE P0012946A DE 936592 C DE936592 C DE 936592C
Authority
DE
Germany
Prior art keywords
trioxyflavone
blood
glucoside
plants
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEP12946A
Other languages
German (de)
Inventor
Eberhard Potratz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmazeutische Fabrik Evers and Co
Original Assignee
Pharmazeutische Fabrik Evers and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmazeutische Fabrik Evers and Co filed Critical Pharmazeutische Fabrik Evers and Co
Priority to DEP12946A priority Critical patent/DE936592C/en
Application granted granted Critical
Publication of DE936592C publication Critical patent/DE936592C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

Verfahren zur Herstellung eines blut- und harnzuckersenkenden Präparates aus trioxyflavonglukosidhaltigen Pflanzenteilen Es ist bereits bekannt, daß durch perorale Gaben pflanzlicher Totalextraktivstoffe, z.B. Bohnen schalen, Beeinflussungen der Blutzuckerwerte ansgelöst werden können.Process for the production of a blood and urine lowering preparation from plant parts containing trioxyflavone glucoside It is already known that by oral administration of total plant extracts, e.g. bean shells, influences the blood sugar levels can be dissolved.

Die vorliegende Erfindung bezieht sich nun auf ein Verfahren zur Herstellung therapeutisch wirksamer, mit dreiwertigen seltenen Erden substituierter Trioxyflavone, die, wie im Tierexperiment mit alloxandiabetischen Ratten festgestellt wurde, insbesondere einen spezifisch blut- und harnzuckersenkenden Effekt ausüben. The present invention now relates to a method for Production of therapeutically effective substitutes with trivalent rare earths Trioxyflavone, which, as found in animal experiments with alloxandiabetic rats in particular have a specific blood- and urine-lowering effect.

Es wurde gefunden, daß man derartige Substanzen gewinnen kann, wenn man trioxyflavonglukosidhaltige Pflanzenteile, z. B. Flores Chamomillale, zur nächst einer Chloroformextraktion, anschließend einer Extraktion und Umkristallisation aus Äther unterzieht und die gewonnenen Trioxyflavone schließlich an dreiwertige seltene Erden nach Fr i edel - C rafts in Form einer Substitutionsbindung anlagert. Als besonders vorteilhaft erwiesen sich für d.ie Anlagerungen in bezug auf technische Durchführung und Ausbeute die Chloride des Cers und Praseodyms. Die auf diese Weise hergestellten Präparate ermöglichen eine gezielte Therapie auf die beim Diabetes gestörten Stoffwechsel- und enzymatischen Vorgänge sowie auf das Zerrtralnervensystem. It has been found that such substances can be obtained if you trioxyflavonglucosidhaltige parts of plants, z. B. Flores Chamomillale, next a chloroform extraction, then an extraction and recrystallization from ether undergoes and the obtained trioxyflavones finally to trivalent rare earths according to Fri edel - C rafts in the form of a substitution bond. The deposits have proven to be particularly advantageous with regard to technical Execution and yield the chlorides of cerium and praseodymium. The preparations produced in this way enable targeted therapy the metabolic and enzymatic processes disturbed in diabetes as well as the Pulling nerve system.

Der Erfindungsgegenstand wird an folgenden Ausführungsbeispielen erläutert: B e i s p i e l 1 500 g Flores Chamomillae werden im Soxhlet für die Dauer von 5 Stunden einer Extraktion mit Chloroform unterzogen. Die Menge des Chloroforms ist gleich der fünffachen des angewandten Extraktionsgutes. Nach Abdampfen des Chloroforms wird der Rückstand mit der auf das Fünffache berechneten Menge go°/oigen Alkohols aufgenommen und damit einer nochmaligen Extraktion von 3 Stunden unterzogen. The subject matter of the invention is based on the following exemplary embodiments Explanation: Ex ample 1 500 g Flores Chamomillae are used in the Soxhlet for the Subjected to extraction with chloroform for 5 hours. The amount of chloroform is equal to five times the amount of extraction material used. After evaporation of the chloroform the residue with the fivefold calculated amount of go% alcohol added and thus subjected to another extraction of 3 hours.

Nach dem Abdampfen des Alkohols bleibt eine braune, schmierige Masse zurück, die nunmehr einer nochmaligen Extraktion mit der fünffachen Menge, bezogen auf die Ausbeute des Rückstandes, äther für 21/2 Stunden unterzogen wird. Dieser Vorgang wird wiederholt. After the alcohol has evaporated, a brown, greasy mass remains back, which is now based on another extraction with five times the amount on the yield of the residue, ether for 21/2 hours is subjected. This The process is repeated.

Nach dem Abdampfen des Äthers bleibt eine braune, kristallinische Masse zurück. Die Aus beute beträgt etwa 15% des Ausgangsmaterials. After the ether has evaporated, it remains brown, crystalline Mass back. The yield is around 15% of the starting material.

536,46 g dieser so gewonnenen, aus 5, 7, 4,' Trioxyflavon bestehenden Substanz werden mit 246,5 g Cerchlorid in 1 l Wasser gelöst, mit 5 g wasserfreiem Aluminiumchlorid versetzt und dann auf 60 bis 70° erhitzt. Die Umsetzung zu dem Cer-Trioxyflavon vollzieht sich analog der Friedel-Craftsschen Reaktion. 536.46 g of this thus obtained, consisting of 5, 7, 4, 'Trioxyflavon existing Substance are dissolved with 246.5 g of cerium chloride in 1 l of water, with 5 g of anhydrous Added aluminum chloride and then heated to 60 to 70 °. Implementation to that Cerium trioxyflavone takes place analogously to the Friedel-Crafts reaction.

Es bildet sich eine komplexe Verbindung, wobei das Cer als Substituent auftritt. Die so gewonnene Substanz stellt ein hellbräunliches Produkt dac, das mit Alkohol. (700/0) ausgewaschen, abgenutscht und bei 50° im Trockenschrank getrocknet wird. Die Ausbeute beträgt etwa 500 g, das Molekulargewicht der kristallinischen Masse 676,6 und der Schmelzpunkt 108,2° C. A complex compound is formed, with cerium as a substituent occurs. The substance obtained in this way represents a light brownish product which with alcohol. (700/0) washed out, suction filtered and dried at 50 ° in a drying cabinet will. The yield is about 500 g, the molecular weight of the crystalline Mass 676.6 and the melting point 108.2 ° C.

B e i s p i e l 2 Unter den gleichen Herstellungsbedingungen und auch unter Verwendung von- Flores Chamomillae als Ausgangssubstanz wird die komplexe Verbindung an Stelle mit Cerium als Substituenten mit Praseodym durchgeführt. Example 2 Under the same manufacturing conditions and also using Flores Chamomillae as the starting substance becomes the complex Compound carried out in place of cerium as a substituent with praseodymium.

Wesentlich für den, Erfindungsgegenstand ist, daß das gewonnene Trioxyflavon mit dreiwertigen seltenen Erden substituiert wird und mit den so gewonnenen Substanzen überraschende, tierexperimentell bestätigte blut- und harnzuckersenkende Wirkungen erzielt wurden. It is essential for the subject of the invention that the trioxyflavone obtained is substituted with trivalent rare earths and with the substances obtained in this way surprising, animal experiments confirmed blood- and urine-lowering effects were achieved.

Claims (2)

PATENTANSPRÜCHE: 1. Verfahren zur Herstellung eines blut- und harnzuckersenkenden Präparates aus trioxyflavonglukosidhaltigen Pflanzenteilen, z. B. PATENT CLAIMS: 1. Process for the production of a blood and urine sugar lowering Preparations from trioxyflavone glucoside-containing parts of plants, e.g. B. Flores Chamomi llaej dadurch gekennzeichnet, daß man die entsprechenden Pflanzenteile zunächst in bekannter Weise mit Chloroform extrahiert, den Chloroformextrakt abdampft, den Rückstand mit Alkohol aufnimmt, die alkoholische Lösung zur Trockne bringt, aus Äther umkristallisiert und das gewonnene Trioxyflavon nach Friedel-Crafts in Gegen wart von Aluminiumchlorid mit den Salzen dreiwertiger seltener Erden umsetzt. Flores Chamomi llaej characterized in that one has the corresponding Plant parts are first extracted in a known manner with chloroform, the chloroform extract evaporates, the residue is taken up in alcohol, the alcoholic solution to dryness brings, recrystallized from ether and the trioxyflavone obtained after Friedel-Crafts reacts in the presence of aluminum chloride with the salts of trivalent rare earths. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß man als Salze der dreiwertigen seltenen Erden die Chloride des Cers und Praseodyms verwendet. 2. The method according to claim 1, characterized in that as Salts of the trivalent rare earths used the chlorides of cerium and praseodymium.
DEP12946A 1954-10-28 1954-10-28 Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants Expired DE936592C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEP12946A DE936592C (en) 1954-10-28 1954-10-28 Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEP12946A DE936592C (en) 1954-10-28 1954-10-28 Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants

Publications (1)

Publication Number Publication Date
DE936592C true DE936592C (en) 1956-01-12

Family

ID=7364348

Family Applications (1)

Application Number Title Priority Date Filing Date
DEP12946A Expired DE936592C (en) 1954-10-28 1954-10-28 Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants

Country Status (1)

Country Link
DE (1) DE936592C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096016A2 (en) * 1982-06-02 1983-12-07 BONOMELLI S.p.A. Therapeutic composition having an antibacterial action and made from a fraction extracted from camomile flower, and the process for the preparation of this fraction

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096016A2 (en) * 1982-06-02 1983-12-07 BONOMELLI S.p.A. Therapeutic composition having an antibacterial action and made from a fraction extracted from camomile flower, and the process for the preparation of this fraction
EP0096016A3 (en) * 1982-06-02 1984-03-21 Bonomelli S.P.A. Therapeutic composition having an antibacterial action and made from a fraction extracted from camomile flower, and the process for the preparation of this fraction
US4584198A (en) * 1982-06-02 1986-04-22 Bonomelli S.P.A. Therapeutic compositions having antibacteric activity comprising a fraction extracted from camomile flowers and process for the preparation of said fraction

Similar Documents

Publication Publication Date Title
DE2656602C3 (en) Method for extracting 2-hydroxymethyl-3,4,5-trihydroxypiperidine from mulberry plants
DE936592C (en) Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants
DE2735455B2 (en) Daunomycin analogs, processes for their preparation and pharmaceuticals containing these compounds
DE1468554C (en) 20 beta tert amino 3 alpha hydroxy (or acyloxy) 5 beta pregnane or its salts and processes for their manufacture
AT202712B (en) Process for the extraction of alkaloids
DE1212542B (en) Process for the preparation of water-soluble diethyl acetals from xanthine derivatives
DE864312C (en) Process for the production of crystallized cardiac glycosides, such as. B. Convallatoxin and Digitoxin
DE1593807C (en) alpha ascine methyl or ethy (ester, as well as a process for their production
DE856739C (en) Process for the synthetic production of adenosine-5-triphosphoric acid
DE1568924C (en) Proscillaridine ketals and process for their preparation
DE1963318C (en) Silybin half ester of silybin with 1 and or or 2 mol of succinic acid and its salts with pharmacologically acceptable inorganic or organic bases, and drugs
DE958924C (en) Process for the preparation of mercury-containing dioxypropane compounds
DE1468554B1 (en) 20beta-tert-amino-3alpha-hydroxy- (or-acyloxy) -5beta-pregnanes or their salts and processes for their preparation
CH338837A (en) Process for the preparation of deserpidic acid or its salts
DE1029825B (en) Process for the preparation of 19-nortestosterone hexahydrobenzoate
DE1016267B (en) Process for the preparation of N-methylol-N-methyl-2-mercaptoimidazole
DE2139124B2 (en) Process for obtaining tetracycline
DE1618265A1 (en) Process for the production of new bile acid derivatives
DE1101415B (en) Process for the preparation of 6ª ‡ -Methyl-17ª ‡ -acetoxy-4-pregnen-3, 20-dione
DE1044820B (en) Process for the preparation of reserpoxidic acid monoesters with free hydroxyl group and their salts
CH482667A (en) Process for the preparation of rutin derivatives
DE1020155B (en) Process for the extraction of new glucosides from Podophyllum species
DE1050506B (en) Process for the production of an active ingredient concentrate from senna drugs
DE1291336B (en) Process for the preparation of 3ª ‡ - (N, N-dimethylaminoacetoxy) -11-oxo-20, 20-bis- (nitratomethyl) -21-nitrato-5ª ‰ -pregnane and acid addition salts thereof
CH210725A (en) Process for the preparation of a monoester of the androstene series.